Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?
University Hospitals and University of Geneva, Geneva, Switzerland. Electronic address: gfrisoni@fatebenefratelli.it.
Giovanni B
GB
Frisoni
Skåne University Hospital and Lund University, Lund, Sweden.
Oskar
O
Hansson
D000544:Alzheimer Disease; D016229:Amyloid beta-Peptides; D015415:Biomarkers; D006801:Humans; D010446:Peptide Fragments; D016875:tau Proteins
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D010446:Peptide Fragments; D016875:tau Proteins